
GC19293
PFK-158
Also known as (E)-1-pyridin-4-yl-3-[7-(trifluoromethyl)quinolin-2-yl]prop-2-en-1-one
PFK-158 is a potent and selective PFKFB3 inhibitor, which shows extensive anti-tumor activity by reducing the uptake of glucose in cancer cells, the production of ATP, the release of lactic acid and inducing apoptosis and autophagy
ChemicalCAS1462249-75-7MW328.29FormulaC18H11F3N2O
- CAS number
- 1462249-75-7
- Molecular weight
- 328.29
- Formula
- C18H11F3N2O
- Solubility
- DMSO : ≥ 30 mg/mL (91·38 mM)
- InChIKey
- IAJOMYABKVAZCN-AATRIKPKSA-N
- Catalogue number
- GC19293
- Brand
- GLPBIO
Computed properties PubChem CID 71730058 · XLogP 3.8 · TPSA 42.9 Ų · H-bond donors 0
- XLogP
- 3.8
- TPSA
- 42.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 3
- Heavy atoms
- 24
SMILES C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F
Computed descriptors from PubChem (CID 71730058), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il